SCHEMBL6404543

SCHEMBL6404543

Cc1ccc(-c2nnc(SCC(=O)OCc3ccccc3)n2-c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.64
LMNA P02545 3/20 0.61
PKM P14618 1/20 0.61
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
CDC25A P30304 1/20 0.59
CDC25B P30305 1/20 0.59
L3MBTL1 Q9Y468 3/20 0.57
ALDH1A1 P00352 6/20 0.56
HPGD P15428 3/20 0.56
HSD17B10 Q99714 3/20 0.56
POLB P06746 1/20 0.56
TSHR P16473 3/20 0.56
ALOX15 P16050 1/20 0.56
USP2 O75604 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
TP53 P04637 1/20 0.55
MDM2 Q00987 1/20 0.55
MAPK1 P28482 1/20 0.55
RXFP1 Q9HBX9 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404213 0.93 MEN1 (0.62) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6409643 0.92 TP53 (0.65) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6402175 0.92 ALDH1A1 (0.60) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6403977 0.90 LMNA (0.56) MAPTLMNAMEN1KMT2AL3MBTL1
SCHEMBL5333083 0.90 MAPT (0.68) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6403249 0.89 MAPK1 (0.57) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6405086 0.89 MAPT (0.61) MAPTLMNAALDH1A1HPGDHSD17B10
SCHEMBL6404073 0.89 ALDH1A1 (0.63) MAPTLMNAPKMMEN1KMT2A
SCHEMBL6403527 0.86 TSHR (0.66) LMNAPKML3MBTL1ALDH1A1HPGD
SCHEMBL6405988 0.86 ALDH1A1 (0.57) LMNAPKMMEN1KMT2ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MAPT 2111/4885LMNA 4116/4885PKM 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.